神经退行症中的代谢障碍与大脑铁积累
Agata Wydrych1, Barbara Pakuła1, Justyna Janikiewicz2
1Laboratory of Mitochondrial Biology and Metabolism, Nencki Institute of Experimental Biology, Warsaw, Poland.
Biochimica et biophysica acta. Bioenergetics
|October 4, 2024
概括
神经退行与大脑铁积累 (NBIA) 涉及罕见的遗传疾病,导致大脑铁积累. 本概述探讨了细胞和代谢变化,重点关注线粒体和脂质,以更好地了解NBIA进展.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 神经退行与大脑铁积累 (NBIA) 包括罕见的遗传性疾病,每百万影响1-3个人.
- NBIA的特征是渐进的神经症状和大脑中异常的铁沉积.
- 已知的亚型包括PKAN,PLAN,MPAN和BPAN,强调了NBIA的异质性.
研究的目的:
- 在NBIA变体中提供细胞平衡和代谢变化的全面概述.
- 专注于线粒体生物能学和脂质代谢作为NBIA的关键驱动因素.
- 为了解这些罕见的神经退行性疾病的进展提供了新的视角.
主要方法:
- 文献综述和对NBIA现有证据的综合.
- 在NBIA中分析细胞平衡和代谢途径.
- 专注于在NBIA变体中的线粒体功能和脂质代谢研究.
主要成果:
- 干扰细胞平衡是NBIA变体中常见的特征.
- 线粒体生物能学和脂质代谢的改变是NBIA病变的核心.
- 有证据表明,这些代谢干扰驱动了NBIA中观察到的渐进的神经退行.
结论:
- NBIA的发病与基本的细胞和代谢功能障碍有关.
- 线粒体和脂质代谢障碍为理解NBIA提供了一个新的框架.
- 对这些途径的进一步研究可能会揭示NBIA的新治疗点.
更多相关视频
04:48Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
Published on: May 4, 2020
8.0K
07:22Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
Published on: November 8, 2017
9.9K
相关概念视频
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
The Blood-brain Barrier
47.0K
Overview
47.0K
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
